Starting May 15, 2026, French shoppers will no longer be able to walk into a wellness store and buy a jar of CBD-infused gummies, a bottle of cannabidiol oil, or a relaxing hemp tea. They will, however, still be allowed to buy CBD flower and roll it into a joint. That paradox — eat it and you’re a criminal, smoke it and you’re a customer — sits at the heart of one of the strangest regulatory moves Europe has seen in years.
The decision, first reported by France 24 on May 7 based on AFP sources, was confirmed in industry briefings by France’s Directorate General for Food (DGAL). It does not introduce a new law. Instead, it activates an old one: a 1997 European Union food-safety rule that has been sitting on the books for nearly three decades, largely unused against the booming cannabidiol sector.
For roughly 2,000 specialised shops across the country and hundreds of farmers cultivating hemp for human consumption, the timing is brutal. CBD edibles are not a fringe product line. Industry groups say they account for around 40 percent of all sales in France’s CBD retail network.
Key Takeaway
France will prohibit the sale of ingestible CBD products — including oils, gummies, capsules, infusions and hemp teas — from May 15, 2026, under enforcement of the EU’s 1997 Novel Food regulation. Smokable CBD flower, e-liquids, resins and cosmetics are not affected. CBD itself remains legal in France if products contain less than 0.3 percent THC. The trade association UPCBD has called the move “absurd” and is preparing a legal appeal. Roughly 2,000 shops and hundreds of growers face direct commercial damage. The underlying issue is not safety but paperwork: cannabinoid extracts have never received formal Novel Food authorization at EU level, even though dossiers have been under review in Brussels for years.
What Exactly Is Being Banned — and What Isn’t
The DGAL’s enforcement plan targets food products only. In regulatory language, that means anything you swallow that contains a cannabinoid extract. Practically, the list looks like this: CBD oils sold with droppers, gummies and chocolates, capsules and softgels, infusion bags and herbal teas with added CBD, syrups, and any beverage containing cannabidiol extract.
What stays on the shelf is everything else. CBD flower — the dried hemp buds people roll or vape — remains legal. So do resins, e-liquids designed for vaping, and topical cosmetics such as creams, balms and serums. Hemp seeds and traditional cold-pressed hemp seed oil, which Europeans have eaten for centuries, are also unaffected because they qualify as “traditional” foods under EU rules.
For consumers, the practical message is simple. Anything you put on your tongue or swallow that contains an extract of cannabidiol is about to disappear from French retail. Anything you inhale, rub on your skin, or that contains only hemp seed material is not.
Why Now? The 1997 Rule Nobody Was Enforcing
To understand this ban, you have to understand a piece of EU bureaucracy called the Novel Food regulation. The rule, originally written in 1997 and updated in 2015, says that any food product not significantly consumed in Europe before May 1997 must be pre-authorized before it can be legally sold. The idea was reasonable enough at the time: don’t let exotic foods, unfamiliar fungi or new biotech ingredients into the European food supply without a safety check.
In January 2019, the European Commission quietly updated its Novel Food Catalogue to classify cannabinoid extracts — including CBD — as novel foods. That single administrative entry meant that, on paper, every CBD oil and gummy sold in Europe needed prior authorization from the European Food Safety Authority (EFSA) before going to market.
In practice, almost no one had it. EFSA evaluations of CBD have been bogged down for years over data gaps, including unresolved questions about liver toxicity at high doses, interactions with medications, and effects on the reproductive system. Industry players filed dossiers, paid fees, and waited. While they waited, national regulators across Europe mostly looked the other way. France’s DGAL itself, according to industry representatives, had been tolerating ingestible CBD under certain conditions. That tolerance is what just ended.
What changed is not the science. It is the political willingness to apply a rule that was already there. May 15 was almost certainly chosen as a symbolic date — the EU’s own Novel Food cut-off is May 15, 1997 — turning the anniversary into the trigger for crackdown.
Why the Industry Is Furious
Paul Maclean, a representative of the French CBD trade body UPCBD, did not mince words when speaking to AFP. “We find this completely absurd,” he said. “Going after all of it is one thing, but just going after edibles makes absolutely no sense.”
His logic is hard to dismiss. If French authorities genuinely believed cannabidiol extracts posed a public-health risk, banning the oils while leaving the smokable flower untouched would be incoherent. Smoking CBD flower delivers the same molecule into the same bloodstream — arguably with additional combustion-related risks that ingestion avoids. The selective ban reads less like a safety measure and more like an administrative box-ticking exercise: edibles happen to fall under food law, flowers and cosmetics do not.
Maclean warned that the move could push hundreds of growers and an estimated 2,000 shops out of business. The industry is now preparing to argue, on appeal, that French authorities are not in fact obliged to apply the EU regulation in this particular way. Other European countries facing the same Novel Food problem have responded with grace periods, formal exemptions, or simply continued tolerance while EFSA finishes its work. France has chosen the strictest possible reading.
The Bigger Picture: Europe’s Patchwork CBD Map
France’s decision lands in the middle of a Europe-wide regulatory tug of war over hemp. The Court of Justice of the European Union ruled in its 2020 Kanavape judgment that CBD is not a narcotic and that member states cannot ban its sale within the EU single market without proportionate public-health justification. That ruling forced France to drop its 2021 attempt to outlaw CBD flower altogether.
But the Court left a door open: member states can still regulate CBD through food law, cosmetics law, or pharmaceutical law. That is the door France is now walking through. Rather than banning CBD outright — which would be illegal under EU law — Paris is reclassifying edible CBD as an unauthorized novel food. The result is the same for retailers: products vanish from shelves. The legal mechanism, however, is different, and harder to challenge in Luxembourg.
What makes the move particularly jarring is that France is, in parallel, moving in the opposite direction on medical cannabis. The country recently confirmed an extension of its medical cannabis pilot programme, allowing thousands of patients continued access to therapeutic cannabinoids. So while one branch of the French state is broadening legal access to cannabis for the sick, another is pulling cannabidiol gummies off wellness-shop shelves. Same plant, two different regulatory universes.
Other EU countries are watching closely. Germany, the Czech Republic and Spain have taken more permissive approaches, while Italy has flip-flopped. The United Kingdom, no longer in the EU, has built its own Novel Food authorization track and is gradually approving CBD products one by one. For readers trying to keep up with the moving picture, our country-by-country guide to cannabis laws in Europe lays out where each member state currently stands. If France’s enforcement holds, it could embolden other governments to follow suit and use the Novel Food framework as a back-door restriction on the cannabidiol economy.
What This Means for Consumers
For French consumers, three things are worth knowing. First, possession and personal use of CBD edibles are not criminalized. The ban targets producers and retailers, not end users. If you bought a bottle of CBD oil last month, you do not need to throw it away or fear prosecution for finishing it.
Second, online cross-border sales become a grey zone. EU rules in principle allow goods legally sold in one member state to circulate freely in others, but French customs may begin intercepting shipments of CBD edibles if the products are deemed to violate French food law. Expect uncertainty here for months.
Third, the wellness market will adapt. Producers are already pivoting toward sublingual sprays marketed as cosmetics, inhalable formats, and topical applications. The cannabidiol molecule is not going anywhere. What is changing is the legally acceptable way to put it into a French body.
Will the Ban Survive Legal Challenge?
That is the open question. The UPCBD and allied industry groups are reportedly building an appeal arguing that the DGAL’s application of the Novel Food rule is disproportionate, inconsistent with the Kanavape ruling, and damaging to a sector that has operated in good faith under prior regulatory tolerance. French administrative courts have a track record of pushing back on CBD restrictions — the Council of State suspended the 2021 flower ban within months.
A parallel push is happening in Brussels, where industry consortia are racing to complete EFSA dossiers that would, in theory, finally grant CBD edibles formal Novel Food authorization. If those approvals come through in 2026 or 2027, the French ban could become moot. If they do not, the legal vacuum will continue to be filled by national crackdowns of exactly this kind.
For now, May 15 stands. Hemp farmers in the Dordogne and shop owners in the Marais are preparing for an upheaval. And consumers across the country are buying their last legal bottles of cannabidiol oil before the shelves go bare.
FAQ
No. CBD remains legal in France as long as the finished product contains less than 0.3 percent THC. What is being prohibited is one specific category of CBD products — ingestible foods like oils, gummies, capsules and infusions — under EU food-safety rules. CBD flower, e-liquids, resins and cosmetics are not affected by this measure.
Legally it is a grey area. EU single-market rules generally permit cross-border sales of goods legally sold elsewhere, but French customs and the DGAL may intercept shipments deemed to violate French food law. The risk is operational and financial rather than criminal — final consumers are not the target of enforcement, but seized parcels and refunded orders will become more common.
No. Pharmaceutical products containing cannabidiol, such as Epidiolex for rare forms of paediatric epilepsy, operate under pharmaceutical law, not food law. They are unaffected by the Novel Food enforcement. France’s separate medical cannabis roadmap, with a 2027 deadline for broader access, is also untouched by this measure.
It is possible. The trade association UPCBD has signalled it will appeal, and French administrative courts have previously suspended government attempts to restrict CBD. A separate route to reversal would be formal EFSA authorization of cannabidiol extracts as a novel food at EU level, which would effectively unlock the market across the bloc. Both processes are slow and outcomes are uncertain.
Disclaimer: This article is intended for general informational and educational purposes only and does not constitute legal, medical or financial advice. Cannabis and CBD regulations vary by country and region and change frequently. Readers should consult qualified legal or healthcare professionals before making decisions based on the content presented here. The Cannex makes no warranty as to the accuracy or completeness of third-party statements cited in this report.
